Nektar Therapeutics (NKTR)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q3 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 3,218,382 | 0.31 | |
| Q2 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 32.85% | 1,574,538 | 0.15 | |
| Q1 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 17.68% | 1,029,684 | 0.10 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.27% | 15,822 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 1.66% | 97,243 | 0.02 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 11.98% | 797,309 | 0.15 | |
| Q3 2019 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 93,997 | 0.62 | |
| Q2 2019 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 50.27% | 95,000 | 0.63 | |
| Q1 2019 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 23.48% | 58,000 | 0.35 | |
| Q1 2018 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 54.19% | 233,000 | 4.06 | |
| Q4 2017 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 6.32% | 29,000 | 0.28 | |
| Q1 2017 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 6.58% | 28,101 | 0.13 | |
| Q3 2016 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 9.63% | 45,495 | 0.15 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.